Matches in Wikidata for { <http://www.wikidata.org/entity/Q37327801> ?p ?o ?g. }
- Q37327801 description "article científic" @default.
- Q37327801 description "article scientifique" @default.
- Q37327801 description "articolo scientifico" @default.
- Q37327801 description "artigo científico" @default.
- Q37327801 description "artículu científicu espublizáu en 2016" @default.
- Q37327801 description "bilimsel makale" @default.
- Q37327801 description "scientific article published on 25 April 2016" @default.
- Q37327801 description "vedecký článok" @default.
- Q37327801 description "vetenskaplig artikel" @default.
- Q37327801 description "videnskabelig artikel" @default.
- Q37327801 description "vědecký článek" @default.
- Q37327801 description "wetenschappelijk artikel" @default.
- Q37327801 description "wissenschaftlicher Artikel" @default.
- Q37327801 description "наукова стаття, опублікована у квітні 2016" @default.
- Q37327801 description "научни чланак" @default.
- Q37327801 description "مقالة علمية نشرت في 25 أبريل 2016" @default.
- Q37327801 name "The efficacy and safety of endostar combined with taxane-based regimens for HER-2-negative metastatic breast cancer patients" @default.
- Q37327801 name "The efficacy and safety of endostar combined with taxane-based regimens for HER-2-negative metastatic breast cancer patients" @default.
- Q37327801 name "The efficacy and safety of endostar combined with taxane-based regimens for HER-2-negative metastatic breast cancer patients" @default.
- Q37327801 type Item @default.
- Q37327801 label "The efficacy and safety of endostar combined with taxane-based regimens for HER-2-negative metastatic breast cancer patients" @default.
- Q37327801 label "The efficacy and safety of endostar combined with taxane-based regimens for HER-2-negative metastatic breast cancer patients" @default.
- Q37327801 label "The efficacy and safety of endostar combined with taxane-based regimens for HER-2-negative metastatic breast cancer patients" @default.
- Q37327801 prefLabel "The efficacy and safety of endostar combined with taxane-based regimens for HER-2-negative metastatic breast cancer patients" @default.
- Q37327801 prefLabel "The efficacy and safety of endostar combined with taxane-based regimens for HER-2-negative metastatic breast cancer patients" @default.
- Q37327801 prefLabel "The efficacy and safety of endostar combined with taxane-based regimens for HER-2-negative metastatic breast cancer patients" @default.
- Q37327801 P1433 Q37327801-6D6DEB1F-90E8-4FC7-8B59-9229386F3A4F @default.
- Q37327801 P1476 Q37327801-298D58CE-8BC4-46A5-A87D-3AD22A7AD621 @default.
- Q37327801 P2093 Q37327801-0808D374-9D30-4D45-8909-C030B6340233 @default.
- Q37327801 P2093 Q37327801-234CFCEC-EDE8-47E9-896C-90221782F2A0 @default.
- Q37327801 P2093 Q37327801-2634A86C-326A-49A5-B841-7E811CEAC3D3 @default.
- Q37327801 P2093 Q37327801-6341EB90-7688-4A7E-963E-EB6F95AECC1D @default.
- Q37327801 P2093 Q37327801-8241A27C-1763-446C-AA7F-24B4F1DC7557 @default.
- Q37327801 P2093 Q37327801-B99A5BC1-CB4A-4FFD-8BBF-8BC6F062A5CD @default.
- Q37327801 P2093 Q37327801-C0FEB858-EC58-4EB2-A9C5-617A978036B8 @default.
- Q37327801 P2093 Q37327801-D9A75309-BB92-40D3-8ECA-8F8AFB81FAFB @default.
- Q37327801 P2093 Q37327801-FCA0163C-4E09-4743-A19F-34F2ED371AD7 @default.
- Q37327801 P2860 Q37327801-091BD197-F310-4586-B96B-4B411C99F7EB @default.
- Q37327801 P2860 Q37327801-12A7891D-9674-4987-AF07-AB4B328E3E70 @default.
- Q37327801 P2860 Q37327801-3ACDB004-F63D-416A-B9F3-B77247EBF214 @default.
- Q37327801 P2860 Q37327801-3B511F91-5265-4F3B-B91D-5E070CAE53FE @default.
- Q37327801 P2860 Q37327801-52FA419B-DA15-4C11-A88D-0D7DC4059CC9 @default.
- Q37327801 P2860 Q37327801-591E4523-460E-4782-943B-CC1594CC7AA9 @default.
- Q37327801 P2860 Q37327801-5EA59CCD-F104-456C-AAB2-B6F2CCE02188 @default.
- Q37327801 P2860 Q37327801-6862A249-6987-46AA-8274-3FDB6FEFBA66 @default.
- Q37327801 P2860 Q37327801-8586E3BF-69FE-4CAB-A652-90FE3000BA6F @default.
- Q37327801 P2860 Q37327801-9DB4A281-D5CE-4854-820F-29CC6C8134EF @default.
- Q37327801 P2860 Q37327801-A44C0E92-4D6E-42D9-A615-826CC170ABA9 @default.
- Q37327801 P2860 Q37327801-B7755E86-83C0-4610-879A-A8123AA65A4E @default.
- Q37327801 P2860 Q37327801-B9697EEA-9E5A-4DC4-9137-83F9BA010500 @default.
- Q37327801 P2860 Q37327801-CB1EACE5-A1B1-4DAF-A923-EB09B3D4625D @default.
- Q37327801 P2860 Q37327801-E22AFF69-5785-454C-8792-FA7812E2E73B @default.
- Q37327801 P2860 Q37327801-F10B97F2-F990-46EB-8398-B34C7F8F18BB @default.
- Q37327801 P2860 Q37327801-F1D495B8-ECEC-4D78-8629-3E63A93CB0CE @default.
- Q37327801 P2860 Q37327801-FA5D34D1-D327-421B-B2E5-EA97113BE2B2 @default.
- Q37327801 P304 Q37327801-63C1113D-7C1E-4FFA-95AF-6FB073C2F69E @default.
- Q37327801 P31 Q37327801-E95BF6C4-F4C6-41DC-A34F-824D7C675CF1 @default.
- Q37327801 P356 Q37327801-F1CE80FA-4960-4185-B130-C6E426DCF1E4 @default.
- Q37327801 P407 Q37327801-5ECED5AF-C301-4C51-BF6D-9D0B7794BE59 @default.
- Q37327801 P433 Q37327801-895E8C73-F845-4FB8-90D6-BEBEFE5C1B5D @default.
- Q37327801 P478 Q37327801-A78318DE-ED6E-439C-9D07-9EDE77B2609B @default.
- Q37327801 P577 Q37327801-48FC86BD-F832-4D42-ABDB-1A4D3278477A @default.
- Q37327801 P698 Q37327801-B777442F-A0DE-47F9-8B1A-5C4E6EA34529 @default.
- Q37327801 P921 Q37327801-D5D150B9-3073-4CDC-BE9E-CD1AB047EF7E @default.
- Q37327801 P932 Q37327801-5462EAA0-68B1-429A-A755-1599A7DA6E12 @default.
- Q37327801 P356 ONCOTARGET.8967 @default.
- Q37327801 P698 27129172 @default.
- Q37327801 P1433 Q1573155 @default.
- Q37327801 P1476 "The efficacy and safety of endostar combined with taxane-based regimens for HER-2-negative metastatic breast cancer patients" @default.
- Q37327801 P2093 "Cheng Huang" @default.
- Q37327801 P2093 "Fan Wu" @default.
- Q37327801 P2093 "Hongyu Zhen" @default.
- Q37327801 P2093 "Jian Liu" @default.
- Q37327801 P2093 "Kan Chen" @default.
- Q37327801 P2093 "Lin Lin" @default.
- Q37327801 P2093 "Nani Li" @default.
- Q37327801 P2093 "Weiwei Huang" @default.
- Q37327801 P2093 "Yi Hong" @default.
- Q37327801 P2860 Q24187214 @default.
- Q37327801 P2860 Q24299560 @default.
- Q37327801 P2860 Q24315369 @default.
- Q37327801 P2860 Q26822432 @default.
- Q37327801 P2860 Q28145232 @default.
- Q37327801 P2860 Q28587604 @default.
- Q37327801 P2860 Q28593600 @default.
- Q37327801 P2860 Q29614729 @default.
- Q37327801 P2860 Q33862216 @default.
- Q37327801 P2860 Q34111700 @default.
- Q37327801 P2860 Q34732915 @default.
- Q37327801 P2860 Q36224981 @default.
- Q37327801 P2860 Q37671720 @default.
- Q37327801 P2860 Q37887823 @default.
- Q37327801 P2860 Q39363137 @default.
- Q37327801 P2860 Q39655433 @default.
- Q37327801 P2860 Q46412217 @default.
- Q37327801 P2860 Q85077949 @default.
- Q37327801 P304 "31501-31507" @default.
- Q37327801 P31 Q13442814 @default.
- Q37327801 P356 "10.18632/ONCOTARGET.8967" @default.
- Q37327801 P407 Q1860 @default.